Beijing Science Sun Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 109.54 million compared to CNY 132.7 million a year ago. Revenue was CNY 109.54 million compared to CNY 132.7 million a year ago.

Net loss was CNY 190.62 million compared to net income of CNY 0.823935 million a year ago. Basic loss per share from continuing operations was CNY 0.3957 compared to basic earnings per share from continuing operations of CNY 0.0017 a year ago. Diluted loss per share from continuing operations was CNY 0.3957 compared to diluted earnings per share from continuing operations of CNY 0.0017 a year ago.